vs
Side-by-side financial comparison of PCB BANCORP (PCB) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
PCB BANCORP is the larger business by last-quarter revenue ($29.2M vs $18.3M, roughly 1.6× ROCKWELL MEDICAL, INC.). On growth, PCB BANCORP posted the faster year-over-year revenue change (11.3% vs -25.6%). PCB BANCORP produced more free cash flow last quarter ($24.4M vs $2.2M). Over the past eight quarters, PCB BANCORP's revenue compounded faster (10.4% CAGR vs -10.1%).
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
PCB vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $29.2M | $18.3M |
| Net Profit | — | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 45.0% | -2.2% |
| Net Margin | — | -3.0% |
| Revenue YoY | 11.3% | -25.6% |
| Net Profit YoY | — | 26.7% |
| EPS (diluted) | $0.65 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $29.2M | $18.3M | ||
| Q3 25 | $30.4M | $15.9M | ||
| Q2 25 | $29.3M | $16.1M | ||
| Q1 25 | $26.9M | $18.9M | ||
| Q4 24 | $26.2M | $24.7M | ||
| Q3 24 | $25.3M | $28.3M | ||
| Q2 24 | $24.2M | $25.8M | ||
| Q1 24 | $23.9M | $22.7M |
| Q4 25 | — | $-554.0K | ||
| Q3 25 | $11.4M | $-1.8M | ||
| Q2 25 | $9.1M | $-1.5M | ||
| Q1 25 | $7.7M | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | $7.8M | $1.7M | ||
| Q2 24 | $6.3M | $343.0K | ||
| Q1 24 | $4.7M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 45.0% | -2.2% | ||
| Q3 25 | 52.3% | -9.9% | ||
| Q2 25 | 43.3% | -8.4% | ||
| Q1 25 | 40.2% | -7.2% | ||
| Q4 24 | 39.3% | -2.1% | ||
| Q3 24 | 42.2% | 6.8% | ||
| Q2 24 | 36.3% | 2.0% | ||
| Q1 24 | 27.2% | -5.8% |
| Q4 25 | — | -3.0% | ||
| Q3 25 | 37.5% | -11.0% | ||
| Q2 25 | 31.0% | -9.3% | ||
| Q1 25 | 28.8% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | 30.8% | 5.9% | ||
| Q2 24 | 25.9% | 1.3% | ||
| Q1 24 | 19.6% | -7.6% |
| Q4 25 | $0.65 | $-0.01 | ||
| Q3 25 | $0.78 | $-0.05 | ||
| Q2 25 | $0.62 | $-0.05 | ||
| Q1 25 | $0.53 | $-0.04 | ||
| Q4 24 | $0.46 | $-0.02 | ||
| Q3 24 | $0.52 | $0.04 | ||
| Q2 24 | $0.43 | $0.01 | ||
| Q1 24 | $0.33 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $207.1M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $390.0M | $37.0M |
| Total Assets | $3.3B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $207.1M | $10.7M | ||
| Q3 25 | $369.5M | $13.6M | ||
| Q2 25 | $263.6M | $12.5M | ||
| Q1 25 | $214.3M | $11.4M | ||
| Q4 24 | $198.8M | $15.7M | ||
| Q3 24 | $193.1M | $12.3M | ||
| Q2 24 | $177.6M | $11.9M | ||
| Q1 24 | $239.8M | $6.6M |
| Q4 25 | $390.0M | $37.0M | ||
| Q3 25 | $384.5M | $37.0M | ||
| Q2 25 | $376.5M | $30.4M | ||
| Q1 25 | $370.9M | $31.5M | ||
| Q4 24 | $363.8M | $32.6M | ||
| Q3 24 | $362.3M | $29.1M | ||
| Q2 24 | $353.5M | $23.5M | ||
| Q1 24 | $350.0M | $20.6M |
| Q4 25 | $3.3B | $57.1M | ||
| Q3 25 | $3.4B | $57.5M | ||
| Q2 25 | $3.3B | $52.6M | ||
| Q1 25 | $3.2B | $54.0M | ||
| Q4 24 | $3.1B | $59.2M | ||
| Q3 24 | $2.9B | $57.1M | ||
| Q2 24 | $2.9B | $53.0M | ||
| Q1 24 | $2.9B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.6M | $2.3M |
| Free Cash FlowOCF − Capex | $24.4M | $2.2M |
| FCF MarginFCF / Revenue | 83.6% | 12.0% |
| Capex IntensityCapex / Revenue | 7.5% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $46.0M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.6M | $2.3M | ||
| Q3 25 | $16.4M | $-1.3M | ||
| Q2 25 | $4.9M | $1.8M | ||
| Q1 25 | $2.3M | $-3.5M | ||
| Q4 24 | $39.0M | $865.0K | ||
| Q3 24 | $11.9M | $4.3M | ||
| Q2 24 | $14.6M | $1.4M | ||
| Q1 24 | $8.2M | $-2.4M |
| Q4 25 | $24.4M | $2.2M | ||
| Q3 25 | $16.2M | $-1.5M | ||
| Q2 25 | $3.8M | $1.7M | ||
| Q1 25 | $1.6M | $-3.5M | ||
| Q4 24 | $34.9M | $470.0K | ||
| Q3 24 | $11.9M | $4.1M | ||
| Q2 24 | $12.8M | $1.2M | ||
| Q1 24 | $6.0M | $-2.5M |
| Q4 25 | 83.6% | 12.0% | ||
| Q3 25 | 53.2% | -9.6% | ||
| Q2 25 | 13.1% | 10.5% | ||
| Q1 25 | 6.0% | -18.8% | ||
| Q4 24 | 133.2% | 1.9% | ||
| Q3 24 | 46.8% | 14.4% | ||
| Q2 24 | 53.1% | 4.5% | ||
| Q1 24 | 25.2% | -11.1% |
| Q4 25 | 7.5% | 0.5% | ||
| Q3 25 | 0.8% | 1.4% | ||
| Q2 25 | 3.7% | 1.0% | ||
| Q1 25 | 2.8% | 0.3% | ||
| Q4 24 | 15.5% | 1.6% | ||
| Q3 24 | 0.1% | 0.7% | ||
| Q2 24 | 7.3% | 1.1% | ||
| Q1 24 | 9.3% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.52× | 2.57× | ||
| Q2 24 | 2.33× | 4.20× | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PCB
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
